TACC1 and central nervous system neoplasm: The identification of the FGFR1: TACC1 fusion and methylation profiling was pivotal in achieving an accurate diagnosis, highlighting the critical role of molecular evaluation as a complement to histopathology in CNS tumor diagnostics.